bind mismatched DNA and other DNA defects that may occur during replication. This complex has also been shown to bind at least some types of damaged DNA, such damages due to chemotherapeutics. We use molecular dynamics simulations to model the changes in the protein/DNA and protein/protein interfaces that occur during such binding events. All-atom explicit-solvent molecular dynamics simulations with advanced sampling methods were applied to completely determine, at atomic resolution, the mechanism of binding of the protein CD44 with the glycosaminoglycan carbohydrate hyaluronan. The results include descriptions of: formation of the protein-carbohydrate complex from separate protein and carbohydrate; conformational switching at the binding site to enhance binding affinity; additional binding affinity enhancement through an order-to-disorder transition in the protein; and inhibition of binding by glycosylation of CD44. These computational results are discussed in the context of and illuminate existing experimental data.
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Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA, USA, 2 Department of Pharmacology, University of California San Diego, La Jolla, CA, USA, 3 Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, IL, USA, 4 Departments of Chemistry and Biochemistry and Pharmacology, Howard Hughes Medical Institute, University of California San Diego, La Jolla, CA, USA. E,Z-farnesyl diphosphate synthase (E,Z-FPPS; Rv1068) and cis-decaprenyl diphosphate synthase (DPPS; Rv2361c) are promising drug targets in Mycobacterium tuberculosis, the causative agent of tuberculosis, due to their essential roles in the early steps of isoprenoid synthesis during the bacterial cell wall biosynthesis. In this work, we performed a series of molecular dynamics (MD) simulations on E,Z-FPP and DPPS both free and in complex with various ligands in order to investigate their dynamic behaviors. Binding pocket volume calculations obtained from the MD trajectories identified several transitions between open and closed states, indicating considerable structural plasticity of the active sites of these proteins, with the largest flexibility found with DPPS. MD simulations on the mutated E,Z-FPPS and DPPS suggested a possible chain elongation mechanisms for the two enzymes which work in series to synthesize the long decaprenyl diphosphate. To incorporate the flexibility of DPPS into our drug discovery protocol, we carried out virtual screening of a library of 39 known DPPS inhibitors with different receptor conformers obtained from the MD simulations, finding better predictive performance with several rarely sampled MD structures than with static, X-ray crystallographic structures. Our results highlight the importance of accounting for protein flexibility in computer-aided drug design targeting E,Z-FPPS and DPPS.
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Study of the Dynamic and Thermodynamic Calcium Induced Transition in the Downstream Regulatory Element Antagonist Modulator (DREAM) using Photothermal Beam Deflection (PBD) Walter G. Gonzalez, Jaroslava Miksovska. Florida International University, Miami, FL, USA. Here we show the implementation of photothermal beam deflection (PBD) as a useful label free technique for the measurement of millisecond and submillisecond kinetics. Moreover, by taking advantage of the photosensitive calcium chelating compound DM-nitrophen, we have been able to photo trigger the release of calcium and consequent binding to four DREAM constructs. The PBD traces for photolysis of Ca 2þ DMNP show a fast 300 ms decay, whereas upon addition of DREAM(65-256) an additional slow phase with a decay of 1 ms can be resolved. Moreover, a construct lacking the first 161 amino acids shows a slower 5 ms decay. The differences in kinetics can be correlated with the oligomerization transition associated with each construct, where DREAM(65-256) undergoes a tetramer to dimer and DREAM(161-256) a monomer to dimer transition upon calcium binding. Furthermore, the slow transition is measured to be exothermic with a concomitant volume expansion. Together, these results establish the implementation of PBD for dynamic and thermodynamic study of calcium induced transitions in DREAM protein. The M2 proton channel from Influenza A virus is essential for the viral lifecycle and is an important drug target. Amino acid mutations in the residues lining the pore of the channel have abrogated clinical efficacy of the previously FDA-approved antiviral agents, amantadine and rimantadine. More than 95% of the circulating strains isolated from human clinical cases bear S31N mutation and a subsequent resistance to the licensed small molecule inhibitors. Efforts in rational drug design targeting S31N M2 channel have been impeded by the limited number of experimental techniques with capabilities for structural characterization of the protein-ligand interaction in native-like membrane mimetic environments. Solution and Solid State Nuclear Magnetic Resonance (NMR) investigations of the recently introduced adamantane analogues suggest multiple orientations of the inhibitor molecules bound in the pore. Position of the substituent moiety in the channel varies for different compounds, unlike the fixed orientation in the wild type channel. Here we report a Solid State NMR investigation of the transmembrane domain of S31N M2 (TMD) proton channel bound to the novel inhibitor molecules, while also incorporated into a lipid bilayer environment. Oriented sample solid state NMR experiments of S31N M2 TMD indicate that the channel is sampling two states with helical tilts of 28 and 33 relative to the bilayer normal. The kink in the monomer between two helical fragments, observed in the wild type M2 TMD bound with amantadine, is absent for the S31N M2 TMD bound to all inhibitor molecules tested to date. Stabilizing interactions are further investigated with Rotational Echo Double Resonance Magic Angle Spinning (REDOR MAS) experiments for measuring distances from the inhibitor to the protein.
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Single Molecule FRET Studies of the NMDA Receptor using Unnatural Amino Acids Drew Dolino 1 , David Cooper 2 , Swarna Ramaswamy 1 , Christy Landes 2 , Vasanthi Jayaraman 1 . 1 UTHealth, Houston, TX, USA, 2 Rice University, Houston, TX, USA. The NMDA receptor is one class of ionotropic glutamate receptors, which are the primary mediators of excitatory neurotransmission in the central nervous system. As such, function and dysfunction of these receptors has been implicated in such physiological and pathological processes as learning and memory, strokes, Alzheimer disease, and Parkinson disease. Studies into the similarly structured AMPA-type glutamate receptor have revealed a relationship between the extent of closure of the agonist-binding domain cleft and activation of the channel, showing a structural mechanism for transduction of signal from binding of ligand to receptor activation. However, neither crystal structures nor more dynamics-based studies using ensemble FRET/LRET show such a correlation when examining the agonist-binding domain of the glycine-binding subunit of the NMDA receptor. Here, we use single molecule FRET to examine more closely the range of conformation states probed by the isolated agonist-binding domain. To perform this, we had to overcome the problem of immutable native cysteines, which resulted in non-specific labeling when using the conventional maleimide-conjugated fluorophores that are regularly used in protein-based FRET studies. Thus, we introduced the unnatural amino acid p-acetylphenylalanine, which contains a unique ketone functional group, at the sites which we wished to test, allowing for specific labeling of the protein. Doing this, we see that while the protein exhibits a peak probability around 33Å when bound both to full agonist glycine and partial agonist ACPC, the protein bound to partial agonist probes a slightly broader range of states than full agonist. From these data, we can infer that while the agonist-binding domain may show similar average extents of cleft closure, irresolvable by crystallography or ensemble LRET, full agonists more narrowly restrict the range of conformational states probed to conformations that allow for channel activation.
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